Skip to Content



Definition: An oral multitargeted tyrosine kinase inhibitor with particular activity against BCR-ABL; used in the treatment of chronic myeloid leukemia, especially in cases with the T315I mutation.

Disclaimer: This site is designed to offer information for general educational purposes only. The health information furnished on this site and the interactive responses are not intended to be professional advice and are not intended to replace personal consultation with a qualified physician, pharmacist, or other healthcare professional. You must always seek the advice of a professional for questions related to a disease, disease symptoms, and appropriate therapeutic treatments.
© Copyright 2018 Wolters Kluwer. All Rights Reserved. Review Date: Sep 19, 2016.